Chad Cowan - 02 Jan 2026 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role: Chief Scientific Officer
Signature: /s/ Douglas Carr, Attorney-in-Fact
Issuer symbol: IPSC
Transactions as of: 02 Jan 2026
Net transactions value: -$1,603
Form type: 4
Filing time: 06 Jan 2026, 16:10:50 UTC
Previous filing: 29 Dec 2025
Next filing: 04 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cowan Chad	Chief Scientific Officer	C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA	/s/ Douglas Carr, Attorney-in-Fact	06 Jan 2026	0002039294

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IPSC	Common Stock	Tax liability	$1,603	-1,611	-0.15%	$0.9950	1,043,476	02 Jan 2026	Direct	F1
holding	IPSC	Common Stock						10,697	02 Jan 2026	By Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
F2	Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.